+ |
DDC | down-regulates quantity
chemical modification
|
tyrosine |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263993 |
|
|
Homo sapiens |
|
pmid |
sentence |
NBK536726 |
Under specific conditions, dopamine can also be synthesized by a minor pathway, in which L-tyrosine is converted into p-tyramine (mediated by AADC), with subsequent hydroxylation to dopamine by the enzyme CYP2D6 (Cytochrome P450 2D6) which is found in the substantia nigra of human brain  |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Catecholamine metabolism |
+ |
DDC | up-regulates quantity
chemical modification
|
tyramine |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263994 |
|
|
Homo sapiens |
|
pmid |
sentence |
NBK536726 |
Under specific conditions, dopamine can also be synthesized by a minor pathway, in which L-tyrosine is converted into p-tyramine (mediated by AADC), with subsequent hydroxylation to dopamine by the enzyme CYP2D6 (Cytochrome P450 2D6) which is found in the substantia nigra of human brain  |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Catecholamine metabolism |
+ |
DDC | down-regulates quantity
chemical modification
|
5-hydroxy-L-tryptophan |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-264013 |
|
|
Homo sapiens |
|
pmid |
sentence |
31024440 |
In serotonergic neurons Trp serves as the precursor for 5-HT. The 5-HT metabolic pathway is initiated by Trp being hydroxylated to the intermediate 5-hydroxytryptophan (5-HTP), which is subsequently decarboxylated to become 5-HT |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Catecholamine metabolism |
+ |
DDC | up-regulates quantity
chemical modification
|
serotonin |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263987 |
|
|
Danio rerio |
|
pmid |
sentence |
23940784 |
AADC is responsible for the decarboxylation step in the catecholamine and dopamine biosynthesis. Dopamine and serotonin can be synthesized by AADC from L-3,4-dihydroxyphenylalanine and 5-hydroxytryptophan, respectively [7]. A deficiency in AADC will lead to reduced biogenic monoamines, including dopamine, norepinephrine, epinephrine, and serotonin |
|
Publications: |
1 |
Organism: |
Danio Rerio |
Pathways: | Catecholamine metabolism |
+ |
DDC | down-regulates quantity
chemical modification
|
L-dopa |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263992 |
|
|
Homo sapiens |
|
pmid |
sentence |
NBK536726 |
Subsequently, L-DOPA is converted into 3,4-dihydroxyphenethylamine (dopamine) through decarboxylation by the enzyme L-3,4-dihydroxyphenylalanine decarboxylase (DOPA decarboxylase) in the pre-synaptic terminal |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Catecholamine metabolism |
+ |
DDC | up-regulates quantity
chemical modification
|
dopamine |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263986 |
|
|
Danio rerio |
|
pmid |
sentence |
23940784 |
AADC is responsible for the decarboxylation step in the catecholamine and dopamine biosynthesis. Dopamine and serotonin can be synthesized by AADC from L-3,4-dihydroxyphenylalanine and 5-hydroxytryptophan, respectively [7]. A deficiency in AADC will lead to reduced biogenic monoamines, including dopamine, norepinephrine, epinephrine, and serotonin |
|
Publications: |
1 |
Organism: |
Danio Rerio |
Pathways: | Catecholamine metabolism |